- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03863561
The Skills, Confidence & Preparedness Index (SCPI) (SCPI)
The Skills, Confidence & Preparedness Index (SCPI) Version 3.0: An Online Version of the SCPI to Evaluate Self-Efficacy of Diabetes Management
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Canadian experts in diabetes care developed the Skills, Confidence & Preparedness Index (SCPI) to assess diabetes self-management in patients. The SCPI is web-based, gives immediate feedback to the healthcare provider, and is associated with glycemia. The SCPI was designed to allow a healthcare provider to individualize the education/support by assessing the three critical dimensions of self-management: knowledge of a skill; confidence in ability to change a behavior; and preparedness to begin implementing the behavior change. Two previous validation studies showed that the SCPI has high internal consistency, reliability, generalizability, and external validity.
Following further focus groups with healthcare providers and patients, the SCPI questions and response scale were edited to further optimize clarity. This study assessed the validity and reliability of a revised, final version of the LMC SCPI in a large sample of diabetes patients, as well as clinical responsiveness of the SCPI to a diabetes self-management education (DSME) program intervention.
This study recruited type 1 and type 2 patients from the waiting rooms of seven LMC Diabetes & Endocrinology specialist clinics in Ontario, Canada. Patients completed the SCPI electronically and their demographic and health information was retrieved from their electronic medical records. A smaller cohort of patients with uncontrolled glycemia were enrolled into a DSME program. Participants completed the SCPI at their baseline visit and their individual results were incorporated into the care paths that were then customized for that participant. The DSME program provided five to seven visits with a diabetes educator over three to four months. Patients completed the SCPI again at their final visit.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ontario
-
Barrie, Ontario, Canada
- LMC Barrie
-
Brampton, Ontario, Canada, L6S 0C9
- LMC Brampton
-
Etobicoke, Ontario, Canada
- LMC Etobicoke
-
Oakville, Ontario, Canada
- LMC Oakville
-
Thornhill, Ontario, Canada
- LMC Thornhill
-
Toronto, Ontario, Canada, M1R 0B1
- LMC Scarborough
-
Toronto, Ontario, Canada
- LMC Bayview
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Waiting room cohort: adult patients with type 1 or type 2 diabetes attending their usual visit with their LMC healthcare provider
DSME cohort: patients with type 1 or type 2 diabetes with a recent A1C ≥ 8.0%
Description
Inclusion Criteria:
- Diagnosis of type 1 or type 2 diabetes
- Age ≥ 18 years
- Ability to read English
- Duration of diabetes ≥ 6 months (DSME cohort only)
- A1C ≥ 8.0% (DSME cohort only)
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Waiting room sample
Patients with type 1 or type 2 diabetes attending an LMC Diabetes & Endocrinology specialist clinic in Ontario completed the SCPI in the waiting room while attending their usual appointment with their healthcare provider.
|
|
|
DSME Intervention
Patients with poor glycemic control (A1C >8.0%) were enrolled into a diabetes self-management education (DSME) program.
The SCPI was completed at their first and last visit and and their individual results were incorporated into the care paths that were then customized for that participant.
The patient met with a diabetes educator five to seven times over the course of three to four months.
|
Diabetes educators customized care paths for their patients based on their individual responses to the SCPI questions.
Patients met with an educator five to seven times over the course of three to four months.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Internal consistency of the SCPI (Skills, Confidence & Preparedness Index)
Time Frame: 24-hours
|
Cronbach's alpha score for the total SCPI score (minimum score 1, maximum score 7) and the three subscales (minimum score 1, maximum score 7) in the waiting room sample.
A higher score indicates greater diabetes self-management.
|
24-hours
|
|
Validity of the SCPI with HbA1c
Time Frame: 24-hours
|
Correlation between the total SCPI score (minimum score 1, maximum score 7) and the three subscale scores (minimum score 1, maximum score 7) with HbA1c in the waiting room sample. A higher SCPI score indicates greater diabetes self-management. |
24-hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Validity of the SCPI with demographic and diabetes variables
Time Frame: 24-hours
|
Correlation between the total SCPI score (minimum score 1, maximum score 7) and age, gender, education, ethnicity, duration of diabetes and diabetes therapy in the waiting room sample. A higher SCPI score indicates greater diabetes self-management. |
24-hours
|
|
Test-retest reliability
Time Frame: one week
|
Applicable to patients from the waiting room sample who completed the SCPI in the clinic and again one week later.
Correlation between the first total SCPI score (minimum score 1, maximum score 7) and the second total SCPI scores.
|
one week
|
|
Floor/ceiling effect of the total SCPI score
Time Frame: 24-hours
|
Assessment of a floor effect (>15% of patients with a minimum score of 1) or a ceiling effect (>15% of patients with a maximum score of 7)
|
24-hours
|
|
SCPI completion time
Time Frame: 24-hours
|
Mean number of minutes it took for patients to complete the SCPI
|
24-hours
|
|
Change in SCPI score
Time Frame: 3 to 4 months
|
Mean change in SCPI total score between the baseline visit and follow-up visit in the DSME cohort
|
3 to 4 months
|
|
Change in HbA1c
Time Frame: 3 to 4 months
|
Mean change in HbA1c between the baseline visit and the follow-up visit in the DSME cohort
|
3 to 4 months
|
|
Association between total SCPI score and HbA1c
Time Frame: Baseline
|
Correlation between SCPI score at baseline and HbA1c at baseline in the DSME cohort
|
Baseline
|
|
Responsiveness of the total SCPI score to an intervention
Time Frame: 3 to 4 months
|
Correlation between change in SCPI score and change in HbA1c in the DSME cohort
|
3 to 4 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Ronnie Aronson, MD, FRCPC, FACE, LMC Diabetes & Endocrinology
Publications and helpful links
General Publications
- Mbuagbaw L, Aronson R, Walker A, Brown RE, Orzech N. The LMC Skills, Confidence & Preparedness Index (SCPI): development and evaluation of a novel tool for assessing self-management in patients with diabetes. Health Qual Life Outcomes. 2017 Jan 31;15(1):27. doi: 10.1186/s12955-017-0606-z.
- Aronson R, Brown RE, Jiandani D, Walker A, Orzech N, Mbuagbaw L. Assessment of self-management in patients with diabetes using the novel LMC Skills, Confidence and Preparedness Index (SCPI). Diabetes Res Clin Pract. 2018 Mar;137:128-136. doi: 10.1016/j.diabres.2017.10.028. Epub 2017 Oct 31.
- Aronson R, Orzech N, Ye C, Brown RE, Goldenberg R, Brown V. Specialist-Led Diabetes Registries and Prevalence of Poor Glycemic Control in Type 2 Diabetes: The Diabetes Registry Outcomes Project for A1C Reduction (DROP A1C). Diabetes Care. 2016 Oct;39(10):1711-7. doi: 10.2337/dc15-2666. Epub 2016 Aug 11.
- Aronson R, Orzech N, Ye C, Goldenberg R, Brown V. Specialist-led diabetes registries and predictors of poor glycemic control in type 2 diabetes: Insights into the functionally refractory patient from the LMC Diabetes Registry database. J Diabetes. 2016 Jan;8(1):76-85. doi: 10.1111/1753-0407.12257. Epub 2015 Mar 24.
- Aronson R, Li A, Brown RE, Walker A, Lyons A, Orzech N. Optimizing Diabetes Self-management Using the Novel Skills, Confidence, and Preparedness Index (SCPI). Diabetes Care. 2019 Oct;42(10):1873-1878. doi: 10.2337/dc19-0699. Epub 2019 Aug 9.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SCPI
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
State University of New York at BuffaloMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Medtronic MiniMed, Inc.RecruitingType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States, Australia, New Zealand
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on Diabetes self-management education (DSME) program
-
Kutahya Health Sciences UniversityCompletedDiabetes Mellitus, Type 2 | Patient Empowerment | EmpowermentTurkey
-
Universiti Putra MalaysiaUniversity of LahoreNot yet recruiting
-
University of Alabama at BirminghamCompletedType 2 DiabetesUnited States
-
University of Texas at AustinActive, not recruitingType 2 DiabetesUnited States
-
Mutah UniversityCompleted
-
Ragae DughmoshHamad Medical Corporation; Qatar University; Qatar National Research Fund; Primary...Not yet recruitingType 2 Diabetes Mellitus (T2DM) | Self-management | Diabetes Self-management
-
Omada Health, Inc.Palo Alto Medical Foundation; Sutter HealthTerminatedType 2 DiabetesUnited States
-
OsakidetzaFondo de Investigacion Sanitaria; Kronikgune-- Association Centre of International... and other collaboratorsCompleted
-
University of MichiganActive, not recruiting
-
University of ArkansasPatient-Centered Outcomes Research InstituteCompletedDiabetes Mellitus, Type 2United States